Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AdaptHealth (AHCO) Return on Sales (2019 - 2025)

Historic Return on Sales for AdaptHealth (AHCO) over the last 7 years, with Q3 2025 value amounting to 0.03%.

  • AdaptHealth's Return on Sales changed 0.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.03% for FY2024, which is 2400.0% up from last year.
  • AdaptHealth's Return on Sales amounted to 0.03% in Q3 2025, which was down 0.0% from 0.02% recorded in Q2 2025.
  • AdaptHealth's 5-year Return on Sales high stood at 0.13% for Q2 2021, and its period low was 0.56% during Q3 2023.
  • Over the past 5 years, AdaptHealth's median Return on Sales value was 0.02% (recorded in 2023), while the average stood at 0.02%.
  • As far as peak fluctuations go, AdaptHealth's Return on Sales plummeted by -5900bps in 2023, and later skyrocketed by 5900bps in 2024.
  • Over the past 5 years, AdaptHealth's Return on Sales (Quarter) stood at 0.03% in 2021, then tumbled by -106bps to 0.0% in 2022, then tumbled by -14291bps to 0.3% in 2023, then skyrocketed by 120bps to 0.06% in 2024, then plummeted by -48bps to 0.03% in 2025.
  • Its Return on Sales was 0.03% in Q3 2025, compared to 0.02% in Q2 2025 and 0.01% in Q1 2025.